These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24194876)

  • 1. Acute treatment with docosahexaenoic acid complexed to albumin reduces injury after a permanent focal cerebral ischemia in rats.
    Eady TN; Khoutorova L; Anzola DV; Hong SH; Obenaus A; Mohd-Yusof A; Bazan NG; Belayev L
    PLoS One; 2013; 8(10):e77237. PubMed ID: 24194876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docosahexaenoic acid complexed to albumin provides neuroprotection after experimental stroke in aged rats.
    Eady TN; Khoutorova L; Obenaus A; Mohd-Yusof A; Bazan NG; Belayev L
    Neurobiol Dis; 2014 Feb; 62():1-7. PubMed ID: 24063996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docosahexaenoic acid complexed to human albumin in experimental stroke: neuroprotective efficacy with a wide therapeutic window.
    Eady TN; Khoutorova L; Atkins KD; Bazan NG; Belayev L
    Exp Transl Stroke Med; 2012 Sep; 4(1):19. PubMed ID: 22980673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Robust docosahexaenoic acid-mediated neuroprotection in a rat model of transient, focal cerebral ischemia.
    Belayev L; Khoutorova L; Atkins KD; Bazan NG
    Stroke; 2009 Sep; 40(9):3121-6. PubMed ID: 19542051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docosahexaenoic acid confers enduring neuroprotection in experimental stroke.
    Hong SH; Belayev L; Khoutorova L; Obenaus A; Bazan NG
    J Neurol Sci; 2014 Mar; 338(1-2):135-41. PubMed ID: 24433927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel aspirin-triggered neuroprotectin D1 attenuates cerebral ischemic injury after experimental stroke.
    Bazan NG; Eady TN; Khoutorova L; Atkins KD; Hong S; Lu Y; Zhang C; Jun B; Obenaus A; Fredman G; Zhu M; Winkler JW; Petasis NA; Serhan CN; Belayev L
    Exp Neurol; 2012 Jul; 236(1):122-30. PubMed ID: 22542947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effect of treatment with human albumin in permanent focal cerebral ischemia: histopathology and cortical perfusion studies.
    Liu Y; Belayev L; Zhao W; Busto R; Belayev A; Ginsberg MD
    Eur J Pharmacol; 2001 Oct; 428(2):193-201. PubMed ID: 11675036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window.
    Belayev L; Liu Y; Zhao W; Busto R; Ginsberg MD
    Stroke; 2001 Feb; 32(2):553-60. PubMed ID: 11157196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effect of SolCD39, a novel platelet aggregation inhibitor, on transient middle cerebral artery occlusion in rats.
    Belayev L; Khoutorova L; Deisher TA; Belayev A; Busto R; Zhang Y; Zhao W; Ginsberg MD
    Stroke; 2003 Mar; 34(3):758-63. PubMed ID: 12624304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docosahexaenoic acid signaling modulates cell survival in experimental ischemic stroke penumbra and initiates long-term repair in young and aged rats.
    Eady TN; Belayev L; Khoutorova L; Atkins KD; Zhang C; Bazan NG
    PLoS One; 2012; 7(10):e46151. PubMed ID: 23118851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docosahexaenoic acid complexed to albumin elicits high-grade ischemic neuroprotection.
    Belayev L; Marcheselli VL; Khoutorova L; Rodriguez de Turco EB; Busto R; Ginsberg MD; Bazan NG
    Stroke; 2005 Jan; 36(1):118-23. PubMed ID: 15569878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRZ 2/579, a novel uncompetitive N-methyl-D-aspartate antagonist, reduces infarct volume and brain swelling and improves neurological deficit after focal cerebral ischemia in rats.
    Liu Y; Belayev L; Zhao W; Busto R; Ginsberg MD
    Brain Res; 2000 Apr; 862(1-2):111-9. PubMed ID: 10799675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LAU-0901, a novel platelet-activating factor antagonist, is highly neuroprotective in cerebral ischemia.
    Belayev L; Khoutorova L; Atkins K; Gordon WC; Alvarez-Builla J; Bazan NG
    Exp Neurol; 2008 Dec; 214(2):253-8. PubMed ID: 18793637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docosahexaenoic Acid therapy of experimental ischemic stroke.
    Belayev L; Khoutorova L; Atkins KD; Eady TN; Hong S; Lu Y; Obenaus A; Bazan NG
    Transl Stroke Res; 2011 Mar; 2(1):33-41. PubMed ID: 21423332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postischemic administration of basic fibroblast growth factor improves sensorimotor function and reduces infarct size following permanent focal cerebral ischemia in the rat.
    Li Q; Stephenson D
    Exp Neurol; 2002 Oct; 177(2):531-7. PubMed ID: 12429198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docosahexaenoic acid reduces cellular inflammatory response following permanent focal cerebral ischemia in rats.
    Chang CY; Kuan YH; Li JR; Chen WY; Ou YC; Pan HC; Liao SL; Raung SL; Chang CJ; Chen CJ
    J Nutr Biochem; 2013 Dec; 24(12):2127-37. PubMed ID: 24139673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A glycine site antagonist ZD9379 reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion.
    Tatlisumak T; Takano K; Meiler MR; Fisher M
    Acta Neurochir Suppl; 2000; 76():331-3. PubMed ID: 11450037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous hyperthermia and its mechanism in the intraluminal suture middle cerebral artery occlusion model of rats.
    Li F; Omae T; Fisher M
    Stroke; 1999 Nov; 30(11):2464-70; discussion 2470-1. PubMed ID: 10548685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
    Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caffeinol confers cortical but not subcortical neuroprotection after transient focal cerebral ischemia in rats.
    Belayev L; Khoutorova L; Zhang Y; Belayev A; Zhao W; Busto R; Ginsberg MD
    Brain Res; 2004 May; 1008(2):278-83. PubMed ID: 15145766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.